Pear Therapeutics

Corey McCann

MD, PhD

Dr. McCann has served as the president and chief executive officer of Pear since August 2013 and as the president of Pear Therapeutics Securities Corporation, a wholly owned subsidiary of Pear, since December 2017. He has also served as a member of the board of directors of NOUS Imaging, Inc, a technology company focused on medical imaging software, since March 2020; as director of Eternia Group LLC since August 2011; and as a director of Eternia Group SRL since May 2021. Previously, Dr. McCann served on the board of Edumedics LLC (now known as SentryHealth), a health and wellness solutions technology company, from January 2013 through October 2019, and Resolute Bio, Inc, a biotechnology company developing peptide-based drugs for chronic metabolic and neurologic disorders from June 2016 through June 2019. Dr. McCann received his BS degree in biology from The Pennsylvania State University, his MD and PhD from Washington University’s St. Louis School of Medicine, and his PhD in neuroscience from Harvard University.

Back